No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal / adverse effects*
-
Antirheumatic Agents / adverse effects*
-
Arthritis, Rheumatoid / drug therapy*
-
Case-Control Studies
-
Humans
-
Infliximab
-
Japan
-
Middle Aged
-
Pneumonia, Pneumocystis / chemically induced*
-
Product Surveillance, Postmarketing
-
Proportional Hazards Models
-
Risk Factors
-
Tumor Necrosis Factor-alpha / immunology*
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab